About
Technology
Issues
FAQ
Links
Official Page
TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization combined with atezolizumab + bevacizumab or on-demand transarterial chemoembolization alone in patients with untreated hepatocellular carcinoma.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.